CD-ROM

Diagnostic Tools for the Immunological and Virological Monitoring of HIV Infection

Presentation type		Track	Abstract category	Text
All Oral abstracts Poster Discussions Poster Exhibition CD-ROM		All A B C D	All Acute and early infection Acute and early infection and management of patients with acquired viral resistance Adherence in adults Adherence in children and adolescents Ageing AIDS related malignancies (KS, lymphoma, cervical and anal carcinoma) including HHV8 infection Animal Models Animal models of transmission, disease resistance and progression Antibody based vaccines Antiretroviral Therapies (strategic categories apply to resource rich and constrained settings) in Children and Adolescents Antiretroviral therapy,clinical trials and cohorts Antiretroviral treatment of people living with HIV for prevention Approaches to counselling and testing in children and caregivers Behavioural surveillance Bioinformatic analysis in drug resistance Bioinformatics analysis of viral diversity in natural history Blood, organ and tissue safety and nosocomial transmission Cellular immunity based vaccines Clinical trials Cohort studies Complementary and traditional medicines and the role of traditional healers in therapy Complications of Anti-Retroviral Therapy and Adherence in Adults and Children Correlates of immune protection Diagnosis of HIV disease Diagnostic Tools for the Immunological and Virological Monitoring of HIV Infection Disease burden – morbidity/mortality Epidemiology of HIV in people who use drugs Epidemiology of sexually transmitted infections (STI) and HIV Estimating the need for HIV treatment Estimating the size of HIV-infected and most at risk population Ethical issues in epidemiological research First line therapy Harm reduction, including reduction of unsafe injecting and other approaches Hepatitis co-infections: (including HBV, HCV) HIV counselling, testing and diagnostic strategies HIV diversity and epidemiology HIV Pathogenesis/Immune Function and Dysfunction HIV Pathogenesis/Latency and Viral Reservoirs HIV superinfections HIV Surveillance, Monitoring and Evaluation HIV tropism, dynamics and fitness HIV-1 and HIV-2 co-infections HIV-2 Host genetics of resistance and susceptibility Immune reconstitution disorders / IRIS Impact of nutrition Innate immunity responses and function in natural history of HIV infection Malaria Male and female condoms and other physical barriers Male circumcision Management of late presenters Measuring and modelling the effect and impact of other HIV prevention interventions Measuring and modelling the effect and impact of PMTCT Measuring and modelling the impact of the HIV epidemic Mechanisms of T cell depletion and dysfunction Methodological Issues and Capacity-Building in Epidemiology and Prevention Research Microbicides Monitoring and evaluation (other) Monitoring and evaluation of HIV prevention, care and treatment Mother to child transmission Mucosal immunity/defenses: responses and dysfunction Mucosal transmission Mycobacteria and TB Natural history, progression and survival Neurologic and psychiatric manifestations, including neurocognitive disorders New HIV testing and diagnostic strategies New monitoring strategies including rapid tests Non pathogenic models of SIV Non-AIDS related co-morbidities (e.g. diabetes, hypertension etc) Non-AIDS related malignancies Novel animal models for vaccine and inhibitor development Novel assays of immune responses Novel Treatment and Prevention Strategies Novel vectors and strategies Nucleic acid based HIV and SIV therapies Opportunistic infections (excluding mycobacterial) Other adverse reactions and complications of ARV therapy Other bacterial infections and malaria and parasitic infections Other complications Other Therapies Paediatric surveillance of HIV Pharmacogenomics Pharmacology, pharmacokinetics, drug formulations Population-based surveys with HIV testing Preclinical development of microbicides Pre-exposure and post-exposure prophylaxis Prevention addressing gender inequalities Prevention for men who have sex with men (MSM) Prevention for people living with HIV Prevention for people who use drugs Prevention for the general population Prevention in institutional settings e.g. workplace, school, prison, military Prevention of mother-to-child transmission Prophylaxis of HIV associated infections; vaccines e.g. pneumococcal, hepatitis and HPV, co-trimoxazole prophylaxis and IPT Research designs in epidemiology Sexually transmitted infections (STI) Simplification strategies (induction/maintenance and use of bPI monotherapy) STI prevention and control Surveillance of HIV (Youth and Adults) Surveillance systems and methods Switch studies Therapy for the heavily pre-treated patient Track B - Clinical Sciences Track C: Epidemiology and Prevention Sciences Transmission and Early Infection Tuberculosis Viral determinants of SIV pathogenesis Viral fitness and tropism assays, utility and application in clinical practice Viral resistance testing in clinical trials and practice Virus-specific cellular immunity When to start therapy
Late breakers only

Posters with this symbol have been selected by the Scientific Programme Committee for distinction based on merit.

Posters with this symbol have an e-Poster available.

CDA091 Abstract Prevalence of hepatotropic viruses HBV +HCV+HDV in HIV infected clients from Northern Nigeria A.S. James1, G. Imade2, U. Placcid2, S. Illiya3, G. Abba3, S. Yohanna4, M. Obed5, U. Tanko6, A. Julius7 1Family Health Internatonal, Laboratory, Sokoto, Nigeria, 2APIN+,Jos Universtiy Teaching Hospital, Laboratory, Jos, Nigeria, 3Family Health Internatonal, Laboratory, Taraba, Nigeria, 4Wukaria General Hospital, Laboratory, Wukari, Nigeria, 5Mambila Baptist Hospital, Laboratory, Gembu, Nigeria, 6Zing General Hospital, Laboratory, Jalingo, Nigeria, 7First Referral Hospital, Laboratory, Mutumbiyu, Nigeria CDA092 Abstract CD81 expression on peripheral blood T-cells and B-cells of HIV and HCV co-infected patients D. Micheloud1, J. González-Nicolás2, J. Berenguer3, R. Lorente4, P. Miralles3, J.C. López3, J. Cosín3, P. Catalán5, M.Á. Muñoz-Fernández4, S. Resino6 1Instituto de Salud Carlos III (Campus Majadahonda), National Centre of Microbiology, Majadahonda, Spain, 2Hospital General Universitario “Gregorio Marañón”, Molecular Immunobiology Laboratory, Madrid, Spain, 3Hospital General Universitario “Gregorio Marañón,” Madrid, Spain, Infectious Diseases-HIV Unit, Madrid, Spain, 4Hospital General Universitario “Gregorio Marañón,” Madrid, Spain, Molecular Immunobiology Laboratory, Madrid, Spain, 5Hospital General Universitario “Gregorio Marañón,” Madrid, Spain, Microbiology Department, Madrid, Spain, 6instituto de Salud Carlos III, National Centre of Microbiology, Madrid, Spain CDA093 Abstract Telomerase activity of peripheral blood mononuclear cells in HIV and HIV/HCV co-infected patients R. Reynoso1, N. Laufer1,2, F. Bolcic1, J. Quarleri1 1National Reference Centre for AIDS, Microbiology, Buenos Aires, Argentina, 2Fernandez Hospital, Infectious Diseases Unit, Buenos Aires, Argentina CDA094 Abstract Hepatitis B,C and HIV co-infection among a cohort of drug users in Nairobi, Kenya T. Muasya Kenya Medical Research Institute, Centre for Virus Research, Hepatitis division, Nairobi, Kenya CDA095 Abstract Hcv genotype do not influence the HCV-specific T cell response in patients with chronic HIV/HCV co-infection N. Rallón1, V. Soriano1, J. García-Samaniego2,3, M. Lopez1, M. Romero2,3, P. Labarga1, J. González-Lahoz1, C. Restrepo1, S. Lozano1, A. Peris1, J.M. Benito1 1Hospital Carlos III, Infectious Diseases Department, Madrid, Spain, 2Hospital Carlos III, Hepatology, Madrid, Spain, 3CIBEREHD, Madrid, Spain CDA096 Abstract A screening system for drugs against hepatitis C virus using recombinant hepatitis C virus expressing renilla luciferae with vigorous replication Y. Kitamura1,2, L. Yu1, C. Aoki1,2, F. Yagyu1,2, G. Gao1, A. Iwamoto2 1Institute of Microbiology, China-Japan Joint Laboratory, Beijing, China, 2University of Tokyo, Institute of Medical Science, Minato-ku, Tokyo, Japan